Detalhe da pesquisa
1.
Multi-target drugs for the treatment of cognitive impairment and fatigue in post-COVID syndrome: focus on Ginkgo biloba and Rhodiola rosea.
J Neural Transm (Vienna)
; 131(3): 203-212, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38347175
2.
Prevalence of COVID-19 and Psychotropic Drug Treatment in Psychiatric In-patients in Germany in 2020: Results from a Nationwide Pilot Survey.
Pharmacopsychiatry
; 56(6): 227-238, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37944561
3.
Neuropsychiatric Drugs Against COVID-19: What is the Clinical Evidence?
Pharmacopsychiatry
; 55(1): 7-15, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35079985
4.
Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disorders.
Eur Arch Psychiatry Clin Neurosci
; 264(5): 459-63, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24253425
5.
Neural Autoantibodies in Cerebrospinal Fluid and Serum in Clinical High Risk for Psychosis, First-Episode Psychosis, and Healthy Volunteers.
Front Psychiatry
; 12: 654602, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33841216
6.
Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers.
Front Psychiatry
; 11: 576877, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33304282
7.
Familial abnormalities of endocannabinoid signaling in schizophrenia.
World J Biol Psychiatry
; 20(2): 117-125, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29521179
8.
Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention.
CNS Drugs
; 32(7): 605-619, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30022465
9.
How gender affects the pharmacotherapeutic approach to treating psychosis - a systematic review.
Expert Opin Pharmacother
; 18(4): 351-362, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28129701
10.
Association of anandamide with altered binocular depth inversion illusion in schizophrenia.
World J Biol Psychiatry
; 18(6): 483-488, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27734750
11.
Therapeutic Potential of Cannabinoids in Psychosis.
Biol Psychiatry
; 79(7): 604-12, 2016 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26852073
12.
What is the promise of nicotinergic compounds in schizophrenia treatment?
Future Med Chem
; 8(17): 2009-2012, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27739330